Nurulimab (BCD-145) is a humanized monoclonal antibody targeting cytotoxic T lymphocyte antigen-4 (anti-CTLA-4). It has potential applications in melanoma research [1].
CAS Number:
[2168561-20-2]
* VAT and and shipping costs not included. Errors and price changes excepted
